GZPHF (Guangzhou Baiyunshan Pharmaceutical Holdings Co) E10: $0.21 (As of Mar. 2026)


GZPHF Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd GZPHF
67 GF Score
Price $2.34
GF Value $3.25
! 6 Warning Signs
View Full Analysis

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co E10?

Guangzhou Baiyunshan Pharmaceutical Holdings Co GZPHF 67 E10 is $0.21 as of Mar. 2026. GuruFocus rates GZPHF with a GF Score™ of 67/100 and a GF Value™ of $3.25. The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Guangzhou Baiyunshan Pharmaceutical Holdings Co's adjusted earnings per share data for the three months ended in Mar. 2026 was $0.159. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.21 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Guangzhou Baiyunshan Pharmaceutical Holdings Co's average E10 Growth Rate was 4.00% per year. During the past 3 years, the average E10 Growth Rate was 5.80% per year. During the past 5 years, the average E10 Growth Rate was 8.70% per year. During the past 10 years, the average E10 Growth Rate was 14.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Guangzhou Baiyunshan Pharmaceutical Holdings Co was 20.70% per year. The lowest was 5.80% per year. And the median was 16.70% per year.

As of today (2026-07-07), Guangzhou Baiyunshan Pharmaceutical Holdings Co's current stock price is $2.34. Guangzhou Baiyunshan Pharmaceutical Holdings Co's E10 for the quarter that ended in Mar. 2026 was $0.21. Guangzhou Baiyunshan Pharmaceutical Holdings Co's Shiller PE Ratio of today is 11.14.

During the past 13 years, the highest Shiller PE Ratio of Guangzhou Baiyunshan Pharmaceutical Holdings Co was 53.54. The lowest was 9.55. And the median was 21.41.


Guangzhou Baiyunshan Pharmaceutical Holdings Co  (OTCPK:GZPHF) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Guangzhou Baiyunshan Pharmaceutical Holdings Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=2.34/0.21
=11.14

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Guangzhou Baiyunshan Pharmaceutical Holdings Co was 53.54. The lowest was 9.55. And the median was 21.41.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Guangzhou Baiyunshan Pharmaceutical Holdings Co E10 Related Terms


Guangzhou Baiyunshan Pharmaceutical Holdings Co E10 Historical Data

* Premium members only.

The historical data trend for Guangzhou Baiyunshan Pharmaceutical Holdings Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangzhou Baiyunshan Pharmaceutical Holdings Co E10 Chart

Guangzhou Baiyunshan Pharmaceutical Holdings Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 0.16 0.19 0.19 0.17

Guangzhou Baiyunshan Pharmaceutical Holdings Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.18 0.17 0.19 0.17 0.21

GZPHF vs MCK, CAH, COR: E10 Comparison

For the Medical Distribution subindustry, Guangzhou Baiyunshan Pharmaceutical Holdings Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangzhou Baiyunshan Pharmaceutical Holdings Co Shiller PE Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Guangzhou Baiyunshan Pharmaceutical Holdings Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Guangzhou Baiyunshan Pharmaceutical Holdings Co's Shiller PE Ratio falls into.


GZPHF
67GF Score
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd GZPHF
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guangzhou Baiyunshan Pharmaceutical Holdings Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Guangzhou Baiyunshan Pharmaceutical Holdings Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.159/116.3033*116.3033
=0.159

Current CPI (Mar. 2026) = 116.3033.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.050 101.400 0.057
201609 0.025 102.400 0.028
201612 0.040 102.600 0.045
201703 0.043 103.200 0.048
201706 0.061 103.100 0.069
201709 0.030 104.100 0.034
201712 0.054 104.500 0.060
201803 0.088 105.300 0.097
201806 0.163 104.900 0.181
201809 0.074 106.600 0.081
201812 0.000 106.500 0.000
201903 0.129 107.700 0.139
201906 0.102 107.700 0.110
201909 0.054 109.800 0.057
201912 0.003 111.200 0.003
202003 0.104 112.300 0.108
202006 0.050 110.400 0.053
202009 0.081 111.700 0.084
202012 0.024 111.500 0.025
202103 0.154 112.662 0.159
202106 0.084 111.769 0.087
202109 0.077 112.215 0.080
202112 0.039 113.108 0.040
202203 0.175 114.335 0.178
202206 0.072 114.558 0.073
202209 0.077 115.339 0.078
202212 0.043 115.116 0.043
202303 0.170 115.116 0.172
202306 0.077 114.558 0.078
202309 0.083 115.339 0.084
202312 0.023 114.781 0.023
202403 0.167 115.227 0.169
202406 0.050 114.781 0.051
202409 0.053 115.785 0.053
202412 -0.027 114.893 -0.027
202503 0.154 115.116 0.156
202506 0.060 114.907 0.061
202509 0.069 115.471 0.069
202512 -0.029 115.832 -0.029
202603 0.159 116.303 0.159

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $0.21 mean?
Guangzhou Baiyunshan Pharmaceutical Holdings Co (GZPHF) has a E10 of $0.21 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Guangzhou Baiyunshan Pharmaceutical Holdings Co and its competitors.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Co's E10 too high?
Guangzhou Baiyunshan Pharmaceutical Holdings Co's current E10 is $0.21. Overall, Guangzhou Baiyunshan Pharmaceutical Holdings Co has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Guangzhou Baiyunshan Pharmaceutical Holdings Co's E10 compare to MCK and CAH?
Guangzhou Baiyunshan Pharmaceutical Holdings Co's E10 of $0.21 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Distribution company?
A good E10 depends on the Medical Distribution industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Guangzhou Baiyunshan Pharmaceutical Holdings Co and its competitors. Guangzhou Baiyunshan Pharmaceutical Holdings Co's current E10 is $0.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Co stock overvalued right now?
Guangzhou Baiyunshan Pharmaceutical Holdings Co (GZPHF) has a current E10 of $0.21. The stock's GF Value™ is $3.25, compared to a current price of $2.34 — trading 28% below its estimated fair value. The current E10 is $0.21. Guangzhou Baiyunshan Pharmaceutical Holdings Co's overall GF Score™ is 67/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Guangzhou Baiyunshan Pharmaceutical Holdings Co (GZPHF), the current E10 is $0.21 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guangzhou Baiyunshan Pharmaceutical Holdings Co (GZPHF) Overvalued in 2026?

Based on GuruFocus' analysis, Guangzhou Baiyunshan Pharmaceutical Holdings Co stock appears to be undervalued. The current stock price of $2.34 is trading 28% below its estimated GF Value™ of $3.25.

Key valuation signals for GZPHF:

  • E10: $0.21
  • GF Value™: $3.25 vs. price of $2.34 (28% below fair value)
  • GF Score™: 67/100 with 6 warning signs

No single metric tells the full story. See the GZPHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Guangzhou Baiyunshan Pharmaceutical Holdings Co Business Description

Address 45 Sha Mian North Street, Liwan District, Guangdong Province, Guangzhou, CHN, 510130
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is engaged in the pharmaceutical and healthcare industry, focusing on the development of a full industrial chain covering research, manufacturing, and distribution. The group operates through five reportable segments. The Modern Chinese Medicine segment involves the R&D, manufacturing, and sale of proprietary Chinese and natural medicines. The Chemical Pharmaceutical Technology segment focuses on chemical drugs, APIs, and intermediates. The Natural Beverages segment produces and sells health-oriented beverage products. The Pharmaceutical Commerce segment is engaged in the wholesale, retail, and import/export of medicines and medical devices. The Other Segments include biotechnology innovation, consumer health, and medical services.
67GF Score

Get the complete analysis for GZPHF

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.34
Price
$3.25
GF Value